Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BoNT-A for TBI Associated Photophobia
NCT06293300Phase 2Recruiting
- Sponsor
- University of Miami
- Start
- Sep 2024
- Primary completion
- Sep 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in photophobia, sponsored by University of Miami. Started Sep 2024; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
photophobia
Beyond the preview
Go deeper on NCT06293300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06293300.